344 related articles for article (PubMed ID: 19269181)
1. Huntingtin as an essential integrator of intracellular vesicular trafficking.
Caviston JP; Holzbaur EL
Trends Cell Biol; 2009 Apr; 19(4):147-55. PubMed ID: 19269181
[TBL] [Abstract][Full Text] [Related]
2. Huntingtin: an iron-regulated protein essential for normal nuclear and perinuclear organelles.
Hilditch-Maguire P; Trettel F; Passani LA; Auerbach A; Persichetti F; MacDonald ME
Hum Mol Genet; 2000 Nov; 9(19):2789-97. PubMed ID: 11092755
[TBL] [Abstract][Full Text] [Related]
3. Hypothesis: Huntingtin may function in membrane association and vesicular trafficking.
Truant R; Atwal R; Burtnik A
Biochem Cell Biol; 2006 Dec; 84(6):912-7. PubMed ID: 17215878
[TBL] [Abstract][Full Text] [Related]
4. Nucleocytoplasmic trafficking and transcription effects of huntingtin in Huntington's disease.
Truant R; Atwal RS; Burtnik A
Prog Neurobiol; 2007 Nov; 83(4):211-27. PubMed ID: 17240517
[TBL] [Abstract][Full Text] [Related]
5. Mutant huntingtin interacts with {beta}-tubulin and disrupts vesicular transport and insulin secretion.
Smith R; Bacos K; Fedele V; Soulet D; Walz HA; Obermüller S; Lindqvist A; Björkqvist M; Klein P; Onnerfjord P; Brundin P; Mulder H; Li JY
Hum Mol Genet; 2009 Oct; 18(20):3942-54. PubMed ID: 19628478
[TBL] [Abstract][Full Text] [Related]
6. Huntingtin-protein interactions and the pathogenesis of Huntington's disease.
Li SH; Li XJ
Trends Genet; 2004 Mar; 20(3):146-54. PubMed ID: 15036808
[TBL] [Abstract][Full Text] [Related]
7. Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins.
Huang CC; Faber PW; Persichetti F; Mittal V; Vonsattel JP; MacDonald ME; Gusella JF
Somat Cell Mol Genet; 1998 Jul; 24(4):217-33. PubMed ID: 10410676
[TBL] [Abstract][Full Text] [Related]
8. Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD rat.
Clemens LE; Weber JJ; Wlodkowski TT; Yu-Taeger L; Michaud M; Calaminus C; Eckert SH; Gaca J; Weiss A; Magg JC; Jansson EK; Eckert GP; Pichler BJ; Bordet T; Pruss RM; Riess O; Nguyen HP
Brain; 2015 Dec; 138(Pt 12):3632-53. PubMed ID: 26490331
[TBL] [Abstract][Full Text] [Related]
9. Molecular aspects of Huntington's disease.
Walling HW; Baldassare JJ; Westfall TC
J Neurosci Res; 1998 Nov; 54(3):301-8. PubMed ID: 9819135
[TBL] [Abstract][Full Text] [Related]
10. Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies.
Borrell-Pagès M; Zala D; Humbert S; Saudou F
Cell Mol Life Sci; 2006 Nov; 63(22):2642-60. PubMed ID: 17041811
[TBL] [Abstract][Full Text] [Related]
11. Huntington's disease: how does huntingtin, an anti-apoptotic protein, become toxic?
Rangone H; Humbert S; Saudou F
Pathol Biol (Paris); 2004 Jul; 52(6):338-42. PubMed ID: 15261377
[TBL] [Abstract][Full Text] [Related]
12. Polyglutamine expansion in huntingtin alters its interaction with phospholipids.
Kegel KB; Sapp E; Alexander J; Valencia A; Reeves P; Li X; Masso N; Sobin L; Aronin N; DiFiglia M
J Neurochem; 2009 Sep; 110(5):1585-97. PubMed ID: 19566678
[TBL] [Abstract][Full Text] [Related]
13. pARIS-htt: an optimised expression platform to study huntingtin reveals functional domains required for vesicular trafficking.
Pardo R; Molina-Calavita M; Poizat G; Keryer G; Humbert S; Saudou F
Mol Brain; 2010 Jun; 3():17. PubMed ID: 20515468
[TBL] [Abstract][Full Text] [Related]
14. In vitro evidence for both the nucleus and cytoplasm as subcellular sites of pathogenesis in Huntington's disease.
Hackam AS; Singaraja R; Zhang T; Gan L; Hayden MR
Hum Mol Genet; 1999 Jan; 8(1):25-33. PubMed ID: 9887328
[TBL] [Abstract][Full Text] [Related]
15. Huntington's disease: degradation of mutant huntingtin by autophagy.
Sarkar S; Rubinsztein DC
FEBS J; 2008 Sep; 275(17):4263-70. PubMed ID: 18637946
[TBL] [Abstract][Full Text] [Related]
16. Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin.
Bao J; Sharp AH; Wagster MV; Becher M; Schilling G; Ross CA; Dawson VL; Dawson TM
Proc Natl Acad Sci U S A; 1996 May; 93(10):5037-42. PubMed ID: 8643525
[TBL] [Abstract][Full Text] [Related]
17. Huntington's disease: new paths to pathogenesis.
Ross CA
Cell; 2004 Jul; 118(1):4-7. PubMed ID: 15242639
[TBL] [Abstract][Full Text] [Related]
18. A cellular model that recapitulates major pathogenic steps of Huntington's disease.
Lunkes A; Mandel JL
Hum Mol Genet; 1998 Sep; 7(9):1355-61. PubMed ID: 9700187
[TBL] [Abstract][Full Text] [Related]
19. Huntingtin facilitates polycomb repressive complex 2.
Seong IS; Woda JM; Song JJ; Lloret A; Abeyrathne PD; Woo CJ; Gregory G; Lee JM; Wheeler VC; Walz T; Kingston RE; Gusella JF; Conlon RA; MacDonald ME
Hum Mol Genet; 2010 Feb; 19(4):573-83. PubMed ID: 19933700
[TBL] [Abstract][Full Text] [Related]
20. Interacting proteins as genetic modifiers of Huntington disease.
Li XJ; Friedman M; Li S
Trends Genet; 2007 Nov; 23(11):531-3. PubMed ID: 17961788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
